Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer

医学 化疗 宫颈癌 阶段(地层学) 外科 子宫颈 病态的 内科学 新辅助治疗 癌症 乳腺癌 古生物学 生物
作者
Hongbing Cai,Hui‐Zhen Chen,Hou‐Han Yin
出处
期刊:Journal of Obstetrics and Gynaecology Research [Wiley]
卷期号:32 (3): 315-323 被引量:87
标识
DOI:10.1111/j.1447-0756.2006.00404.x
摘要

Abstract Aim: To determine the most effective treatment and long‐term outcome of patients with stage IB carcinoma of the cervix. Methods: From January 1999 to December 2001, 106 women with cervical cancer stage IB received neoadjuvant chemotherapy ( n = 52) or primary surgery ( n = 54). These were randomly assigned. Clinical effects and pathological changes were simultaneously recorded. Results: The overall clinical response rate was 84.6% and included a complete response (CR) in four patients (7.7%), partial response (PR) in 40 patients (76.9%), and stable disease (SD) in the remaining eight patients (15.4%). Surgery revealed positive nodes in 9.6% neoadjuvant chemotherapy group patients and in 29.6% primary surgery group patients ( P = 0.014). Similar results occurred with vascular space involvement: 27.8% in the primary surgery group compared to 9.6% in the neoadjuvant chemotherapy group ( P = 0.024). However, parametrial infiltration was found in 7.4% of the patients in the primary surgery group, while only 3.8% showed it in the neoadjuvant chemotherapy group ( P = 0.679). The overall 5‐year survival rate was significantly higher for all patients who received neoadjuvant chemotherapy (84.6%) than for the control group (75.9%) ( P = 0.0112). The median survival time in patients with complete response and partial response to chemotherapy (83.3 months) was significantly higher than that of patients with stable disease to chemotherapy (55.2 months) ( P = 0.0049). 27.3% of patients developed recurrent disease within 5 years of the primary treatment. The women with recurrence included partial response in six patients (60.0%), and stable disease in four patients (40.0%). For the other patients there was partial response and complete response in 38 patients (90.5%), and stable disease in the remaining four patients (9.5%) ( P = 0.035). Conclusion: Neoadjuvant chemotherapy can effectively eliminate the pathological risk factors and improve long‐term survival in patients with locally advanced cervical cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
安之发布了新的文献求助30
1秒前
Hello应助量子星尘采纳,获得10
1秒前
luqi完成签到,获得积分10
2秒前
李七七发布了新的文献求助10
3秒前
大个应助量子星尘采纳,获得10
4秒前
不想学习的颓废少女完成签到 ,获得积分10
5秒前
lzx发布了新的文献求助10
7秒前
Lucas应助星沉静默采纳,获得10
8秒前
luoshikun发布了新的文献求助10
8秒前
8秒前
Eber完成签到,获得积分10
8秒前
sml完成签到,获得积分10
8秒前
隐形曼青应助量子星尘采纳,获得10
9秒前
Zerone01001完成签到,获得积分10
10秒前
于忠波完成签到,获得积分10
11秒前
徐栩栩完成签到,获得积分10
11秒前
zsy111完成签到,获得积分10
11秒前
11秒前
12秒前
sml发布了新的文献求助10
12秒前
狗狗碎碎完成签到,获得积分20
13秒前
Zzz完成签到,获得积分10
14秒前
14秒前
ZZ完成签到,获得积分10
15秒前
卓头OvQ完成签到,获得积分10
16秒前
Margaery关注了科研通微信公众号
17秒前
赘婿应助宫城采纳,获得10
17秒前
张光光发布了新的文献求助10
18秒前
归尘发布了新的文献求助10
18秒前
ddd完成签到,获得积分10
19秒前
ding应助闾丘剑封采纳,获得10
19秒前
19秒前
20秒前
Lucas应助lzx采纳,获得10
20秒前
心灵美灵凡完成签到,获得积分10
21秒前
21秒前
21秒前
21秒前
可爱无招完成签到,获得积分10
22秒前
Orange应助enchanted采纳,获得10
22秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989469
求助须知:如何正确求助?哪些是违规求助? 3531722
关于积分的说明 11254409
捐赠科研通 3270221
什么是DOI,文献DOI怎么找? 1804946
邀请新用户注册赠送积分活动 882113
科研通“疑难数据库(出版商)”最低求助积分说明 809176